{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T11:57:32Z","timestamp":1648555052662},"reference-count":6,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.ijantimicag.2009.06.018","type":"journal-article","created":{"date-parts":[[2009,8,14]],"date-time":"2009-08-14T09:39:40Z","timestamp":1250242780000},"page":"471-473","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy of moxifloxacin or gatifloxacin as prophylaxis against experimental murine Brucella melitensis infection"],"prefix":"10.1016","volume":"34","author":[{"given":"Helen S.","family":"Atkins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon D.","family":"Brew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas R.","family":"Laws","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel E.","family":"Thirlwall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alastair P.","family":"MacMillan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy J.G.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.H.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2009.06.018_bib1","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1086\/501359","article-title":"Efficacy of gentamicin plus doxycycline versus streptomycin plus doxycycline in the treatment of brucellosis in humans","volume":"42","author":"Roushan","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2009.06.018_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1179\/joc.2008.20.1.33","article-title":"In vitro activity of tigecycline, tetracycline and fluoroquinolones against Brucella melitensis","volume":"20","author":"Kilic","year":"2008","journal-title":"J Chemother"},{"key":"10.1016\/j.ijantimicag.2009.06.018_bib3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1128\/AAC.43.1.194","article-title":"In vitro activities of six new fluoroquinolones against Brucella melitensis","volume":"43","author":"Trujillano-Martin","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.06.018_bib4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1159\/000088122","article-title":"In vitro activities of various antimicrobials against Brucella melitensis strains in the Aegean region in Turkey","volume":"14","author":"Yamazhan","year":"2005","journal-title":"Med Princ Pract"},{"key":"10.1016\/j.ijantimicag.2009.06.018_bib5","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1046\/j.1469-0691.2002.00416.x","article-title":"In vitro activities of new quinolones against Brucella melitensis isolated in a tertiary-care hospital in Turkey","volume":"8","author":"Kocag\u00f6z","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2009.06.018_bib6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1179\/joc.2008.20.1.58","article-title":"Comparison of rifampicin and moxifloxacin efficacy in an experimental model of animal brucellosis","volume":"20","author":"Sezak","year":"2008","journal-title":"J Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857909003227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857909003227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T00:51:34Z","timestamp":1558486294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857909003227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":6,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0924857909003227"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2009.06.018","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}